REPLIGEN CORP
For the period ended Jun 30, 2025. Filed Aug 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 7, 2025
RGEN$173.49+3.0%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Condensed Consolidated Balance Sheets as of June 30, 2025 and December 31, 2024 (Unaudited)
ANCE SHEETS
(Unaudited, amounts in thousands, except share data)
| June 30, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $708,855 | $757,355 |
| Accounts receivable, net of reserves of $2,197 and $1,832 at June 30, 2025 and December 31, 2024, respectively | 156,952 | 134,115 |
| Inventories, net | 155,862 | 142,964 |
| Prepaid expenses and other current assets | 35,196 | 31,607 |
| Total current assets | 1,056,865 | 1,066,041 |
| Noncurrent assets: | ||
| Property, plant and equipment, net | 193,489 | 197,738 |
| Intangible assets, net | 406,213 | 397,897 |
| Goodwill | 1,114,009 | 1,030,995 |
| Deferred tax assets | 800 | 749 |
| Operating lease right of use assets | 127,682 | 135,378 |
| Other noncurrent assets | 2,569 | 868 |
| Total noncurrent assets | 1,844,762 | 1,763,625 |
| Total assets | $2,901,627 | $2,829,666 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $25,625 | $32,134 |
| Operating lease liability | 16,043 | 15,104 |
| Current contingent consideration | 5,168 | 17,126 |
| Accrued liabilities | 76,176 | 62,423 |
| Total current liabilities | 123,012 | 126,787 |
| Noncurrent liabilities: | ||
| Convertible Senior Notes due 2028, net | 533,725 | 525,567 |
| Deferred tax liabilities | 23,326 | 22,775 |
| Noncurrent operating lease liability | 136,296 | 145,576 |
| Noncurrent contingent consideration | 6,658 | 19,662 |
| Other noncurrent liabilities | 16,869 | 16,581 |
| Total noncurrent liabilities | 716,874 | 730,161 |
| Total liabilities | 839,886 | 856,948 |
| Commitments and contingencies (Note 11) | ||
| Stockholders' equity: | ||
| Preferred stock, $0.01 par value, 5,000,000 shares authorized, no shares issued or outstanding | — | — |
| Common stock, $0.01 par value; 80,000,000 shares authorized; 56,253,009 shares at June 30, 2025 and 56,091,677 shares at December 31, 2024 issued and outstanding | 563 | 561 |
| Additional paid-in capital | 1,634,844 | 1,617,336 |
| Accumulated other comprehensive loss | (1,716) | (52,533) |
| Retained earnings | 428,050 | 407,354 |
| Total stockholders’ equity | 2,061,741 | 1,972,718 |
| Total liabilities and stockholders’ equity | $2,901,627 | $2,829,666 |
Condensed CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited, amounts in thousands, except share and per share data)
| Three Months EndedJune 30, | Six Months EndedJune 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Revenue: | ||||
| Product | $182,329 | $158,804 | $351,466 | $311,950 |
| Royalty and other revenue | 37 | 35 | 72 | 71 |
| Total revenue | 182,366 | 158,839 | 351,538 | 312,021 |
| Costs and operating expenses: | ||||
| Cost of goods sold | 91,224 | 77,314 | 169,639 | 153,705 |
| Research and development | 13,958 | 10,575 | 26,882 | 21,813 |
| Selling, general and administrative | 71,227 | 65,481 | 142,482 | 127,284 |
| Change in fair value of contingent consideration | (7,939) | — | (7,939) | — |
| Total costs and operating expenses | 168,470 | 153,370 | 331,064 | 302,802 |
| Income from operations | 13,896 | 5,469 | 20,474 | 9,219 |
| Other income (expenses): | ||||
| Investment income | 6,585 | 9,411 | 13,899 | 18,404 |
| Interest expense | (5,354) | (5,118) | (10,604) | (10,147) |
| Amortization of debt issuance costs | (414) | (520) | (827) | (1,003) |
| Other income (expenses), net | 3,502 | (215) | 3,216 | (3,751) |
| Other income, net | 4,319 | 3,558 | 5,684 | 3,503 |
| Income before income taxes | 18,215 | 9,027 | 26,158 | 12,722 |
| Income tax provision | 3,349 | 3,314 | 5,462 | 3,713 |
| Net income | $14,866 | $5,713 | $20,696 | $9,009 |
| Earnings per share: | ||||
| Basic | $0.26 | $0.10 | $0.37 | $0.16 |
| Diluted (Note 13) | $0.26 | $0.10 | $0.37 | $0.16 |
| Weighted average common shares outstanding: | ||||
| Basic | 56,234 | 55,884 | 56,179 | 55,838 |
| Diluted (Note 13) | 56,510 | 56,434 | 56,509 | 56,477 |
| Net income | $14,866 | $5,713 | $20,696 | $9,009 |
| Other comprehensive income (loss): | ||||
| Foreign currency translation adjustment | 46,125 | (1,503) | 50,817 | (6,637) |
| Comprehensive income | $60,991 | $4,210 | $71,513 | $2,372 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.